Zyla Life Sciences Announces Unaudited Consolidated Earnings Results for the Third Quarter Ended September 30, 2019
Zyla Life Sciences announced unaudited consolidated earnings results for the third quarter ended September 30, 2019. For the quarter, the company announced total revenue of $22,386,000 compared to $8,153,000 for the same period a year ago. Loss from operations was $7,663,000 compared to $22,454,000 for the same period a year ago. Net loss was $10,290,000 compared to $51,227,000 for the same period a year ago.